Preclinical Evaluation of a New ECCO2R Setup.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)
PMID:

Abstract

Low flow extracorporeal carbon dioxide removal (ECCO2R) is a promising approach to correct hypercapnic lung failure, facilitate lung protective ventilation in acute respiratory distress syndrome and to possibly prevent the application of invasive ventilation. However, the predominant availability of adult membrane lungs (MLs) at most intensive care units are burdens for low flow ECCO2R that intends to reduce cannula size and promote the mobility of the patients. Herein, in a mock setup, we combine the idea of a low flow ECCO2R and the use of adult MLs by installing a recirculation channel into the circuit and comparing the new setup to an already clinically established setup, "the Homburg lung." Furthermore, to make stronger reference to hypercapnic respiratory failure, we investigate the influence of CO2 partial pressure in blood on CO2 removal of both setups. A linear association between CO2 partial pressure in blood and CO2 removal of the ML in the physiologically relevant range was observed. To understand this linear dependence, a simplified mathematical model was proposed. Our new ECCO2R mock setup combines the idea of a low flow ECCO2R and an adult size ML. It shows a reasonable alternative to the current available low flow setups based on pediatric MLs.

Authors

  • Leonie S Schwärzel
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Anna M Jungmann
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Nicole Schmoll
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Stefan Caspari
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Frederik Seiler
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Ralf M Muellenbach
    Department of Anaesthesiology and Critical Care, Campus Kassel of the University of Southampton, Kassel, Germany.
  • Moritz Bewarder
    Department of Internal Medicine I, University Hospital of Saarland, Homburg, Germany.
  • Quoc Thai Dinh
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Robert Bals
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Philipp M Lepper
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.
  • Albert J Omlor
    From the Department of Internal Medicine V-Pneumology, Allergology and Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany.